Verteporfin
 |
|
10V064,15mg/Vial 現行藥物外觀
中文名:維視達乾粉
廠牌:諾華
|
|
| Product
name |
|
| Dosage
form |
|
| Indications |
| Classic choroidal neovascular membrane, Subfoveal |
|
| Administration
& Dosage |
Adult
Classic choroidal neovascular membrane, Subfoveal:
6 mg/m2 IV infusion for 10 minutes; followed by light therapy 5 mins after finishing verteporfin infusion. Light dose is 50 J/cm(2) of neovascular lesion at intensity of 600 mW/cm(2) over 83 sec
Pediatric
Safety and effectiveness have not been established. |
|
| Contraindication |
hypersensitivity to verteporfin products;porphyria.
|
|
| Precaution |
|
| Adverse
reaction |
Common: injection site reaction, photosensitivity; headache;
visual disturbance.
Serious: atrial fibrillation,hypertension, peripheral vascular disease; malignant neoplasm of gastrointestinal tract; anemia, intraocular hemorrhage; increased liver function test; abnormal vision,cataract.
|
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
1)IV infusion for 10 minutes.
2)Avoid extravasation; if extravasation occurs, stop infusion, apply cold compresses, and thoroughly protect area from direct light until swelling and discoloration have faded.
3)Following injection, avoid exposure of skin or eyes to direct sunlight or bright indoor light for 5 days.
|
|
